16 Nov FDA AdComm – Inhaled ciprofloxacin for non-CF bronchiectasis
Dear All: A Federal Register notice has been released announcing a 16 Nov 2017 FDA Antimicrobial Drugs Advisory Committee meeting to review Bayer’s inhaled ciprofloxacin for reduction of
29 September 2017
No Comments